We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Cardiac Blood Test Predicts Post-Operative Complications

By HospiMedica International staff writers
Posted on 06 Jan 2020
A new study suggests that preoperative measurement of N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) can predict adverse outcomes after most types of surgery.

Researchers from nine countries, including the University of Montreal (Canada), McMaster University (Hamilton, ON, Canada), Hospital Israelita Albert Einstein (São Paulo, Brazil), and other institutions conducted a cohort study to examine if higher pre-operative levels of NT-proBNP can predict post-surgical cardiac and vascular complications. More...
The study included 10,402 patients (45 years of age or older) undergoing non-cardiac surgery. All patients had NT-proBNP levels measured before surgery and troponin T levels measured daily for up to three days after surgery.

The results showed that compared with patients with preoperative NT-proBNP values less than 100 pg/mL, patients with levels of 100-200 pg/mL, 200-1,500 pg/mL, and 1500 pg/mL or greater were associated with adjusted hazard ratios of 2.27, 3.63, and 5.82, respectively. Corresponding incidences of the composite of vascular death and myocardial injury after noncardiac surgery (MINS) were 12.3% , 20.8%, and 37.5%, respectively. Preoperative NT-proBNP values were also significantly associated with 30-day all-cause mortality. The study was published on December 24, 2109, in Annals of Internal Medicine.

"Any type of surgery has the potential to cause damage to heart tissue, through blood clot formation, long periods of inflammation, or bleeding,” said senior author cardiologist Professor PJ Deveraux, MD, of McMaster University, and the Population Health Research Institute (PHRI; Hamilton, Ontario, Canada). “As a result of these findings, doctors can predict who is at greater risk of heart attacks and other negative vascular events after surgery.”

“This simple blood test can be done quickly and easily as part of patient's pre-operative evaluation, and can help patients better understand their risk of post-operative complications and make informed decisions about their surgery,” said lead author Emmanuelle Duceppe, MD, of the Centre Hospitalier de l'Universite de Montreal (CHUM; Canada), and associate researcher at PHRI. “This blood test is twenty times cheaper than more time-consuming tests such as cardiac stress tests and diagnostic imaging.”

NT-proBNP is a non-active prohormone that is released from the same molecule that produces B-type natriuretic peptide (BNP). Both BNP and NT-proBNP are released in response to changes in pressure inside the heart that are associated with heart failure (HF) and other cardiac problems. Normal levels of NT-proBNP are lower than 125 pg/mL for patients aged up to 74 years, and less than 450 pg/mL for patients aged 75-99 years.

Related Links:
University of Montreal
McMaster University
Hospital Israelita Albert Einstein



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Patient Monitoring System
AlarmSense
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.